🧪 HIV-1/2 TEST SET 🧪
Fast. Accurate. Confidential Health Screening.
The HIV-1/2 Test Set is designed for quick and reliable detection of HIV antibodies. It delivers accurate results, supports early diagnosis, and is easy to use. Ideal for clinics, laboratories, and personal screening, it ensures dependable health monitoring with speed, privacy, and confidence when it matters most.
SALES COUNT DOWN
🧪 HIV-1/2 TEST SET 🧪
Professional In-Vitro Diagnostic Rapid Screening Device
1. PRODUCT OVERVIEW
The HIV-1/2 Test Set is a rapid in-vitro diagnostic device designed for the qualitative detection of antibodies to Human Immunodeficiency Virus type 1 (HIV-1) and type 2 (HIV-2) in human whole blood, serum, or plasma specimens.
This test is intended for professional healthcare use only and is commonly applied in clinical screening, diagnostic laboratories, hospitals, and public health programs. It provides a fast preliminary result that assists healthcare professionals in identifying individuals who may require further confirmatory testing.
The device is designed to support early screening efforts, which play a critical role in timely diagnosis, treatment initiation, and public health management.
2. INTENDED USE
The HIV-1/2 Test Set is intended for:
Rapid preliminary screening of HIV-1 and HIV-2 antibodies
Use in clinical and laboratory environments
Support for public health surveillance and outreach programs
Assistance in identifying individuals requiring confirmatory testing
⚠️ Important: This test provides preliminary results only. Reactive results must be confirmed using supplementary laboratory testing methods in accordance with established medical guidelines.
3. PRINCIPLE OF THE TEST
The HIV-1/2 Test Set is based on an immunochromatographic assay principle.
When a patient sample is applied to the test device, it migrates along the test strip by capillary action. If HIV-1 or HIV-2 antibodies are present in the sample, they will bind to specific recombinant antigens embedded within the test system.
This antigen-antibody reaction produces a visible line on the test device.
A control line (C) confirms that the test is functioning correctly
A test line (T) indicates the presence of HIV-1/2 antibodies (preliminary reactive result)
The absence of a test line indicates a non-reactive result, provided the control line appears correctly.
4. KEY FEATURES
⚡ Rapid Results
Provides results within minutes, allowing healthcare professionals to make timely screening decisions.
🎯 High Screening Performance
Engineered for reliable detection of HIV-1 and HIV-2 antibodies when used according to instructions.
🧪 Simple Procedure
Designed for ease of use by trained medical personnel with minimal procedural complexity.
📊 Clear Result Interpretation
Visual test lines allow for straightforward reading and interpretation in clinical environments.
🏥 Professional Use Design
Suitable for structured healthcare settings including hospitals, clinics, laboratories, and outreach programs.
5. CLINICAL APPLICATIONS
The HIV-1/2 Test Set is commonly used in:
Hospitals and emergency departments
Clinical diagnostic laboratories
Voluntary counseling and testing (VCT) centers
Community health screening initiatives
Public health awareness and surveillance programs
Mobile and outreach medical services
6. TEST PROCEDURE SUMMARY
(Refer to manufacturer instructions for full procedural details.)
Collect the appropriate specimen (whole blood, serum, or plasma)
Apply the required volume of sample to the test device
Add buffer solution if required
Allow the test to run for the specified time
Interpret results based on the appearance of control and test lines
Results should be read within the recommended time window to ensure accuracy.
7. INTERPRETATION OF RESULTS
Non-Reactive: Only the control line appears
Preliminary Reactive: Both control and test lines appear
Invalid: Control line does not appear (test must be repeated)
⚠️ Any reactive result must be confirmed with additional laboratory-based diagnostic testing before final clinical diagnosis.
8. LIMITATIONS
This test is a screening tool only and does not confirm HIV infection
Negative results do not completely rule out infection, especially during the window period
Results should always be interpreted alongside clinical evaluation and patient history
Improper sample handling may affect test accuracy
9. STORAGE AND HANDLING
Store in a dry environment as specified by manufacturer guidelines
Avoid exposure to excessive heat, moisture, or direct sunlight
Do not use after expiration date
Ensure proper handling of biological samples following biosafety protocols
10. QUALITY AND SAFETY INFORMATION
The HIV-1/2 Test Set is manufactured under controlled conditions to ensure consistent quality and performance. It should only be used by trained healthcare professionals following standard infection prevention and control procedures.
Proper use ensures safe handling of specimens and reliable screening outcomes.
11. PUBLIC HEALTH IMPORTANCE
Early detection of HIV is a critical component of global health strategies aimed at reducing transmission and improving patient outcomes. Rapid screening tools such as this support:
Early identification of potential cases
Faster referral for confirmatory testing
Improved patient counseling and care pathways
Strengthened disease surveillance systems
12. SUMMARY
The HIV-1/2 Test Set is a reliable, rapid screening device designed for professional healthcare use. It supports early detection efforts by providing quick preliminary results that assist in clinical decision-making and public health management.
While not a standalone diagnostic tool, it plays a vital role in structured HIV testing algorithms when used alongside confirmatory laboratory methods.
Click on “Order Now” to get yours